Last reviewed · How we verify
Follicular non-Hodgkin's lymphoma
Approved treatments
- Zevalin · Spectrum Pharms
Zevalin works by binding to CD20 on B cells and delivering a radioactive dose that kills the cells. - Oncovin · University of Colorado, Denver
- Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Blenoxane · Bristol-Myers Squibb
Bleomycin works by binding to DNA and causing strand breaks, which ultimately leads to cell death. - Cortone
- Treanda · Baxter
Treanda works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and grow. - Decadron · Generic (originally Merck)
- adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- prednison · Wen Zhang
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Rodinolone
- Deltasone · Generic (originally Schering)
- Leukeran · Waylis
Leukeran works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - Oncovin · Pfizer Inc.
- Oncovin · Pfizer Inc.
- Liposomal Doxorubicin · Pfizer
- Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system. - Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Copiktra · Secura
Copiktra works by blocking an enzyme that helps cancer cells grow and multiply. - Bendamustin · Meir Medical Center
- Prelone · Generic (originally Schering)
- Hydroxydaunomycin · Weill Medical College of Cornell University
- prednisolon · Hannover Medical School
- Zevalin · Spectrum Pharmaceuticals, Inc
- Adriamycin · Johann Wolfgang Goethe University Hospital
- Methylprednisolon · Leiden University Medical Center
- Zydelig · University of Maryland, Baltimore
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Follicular non-Hodgkin's lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Follicular non-Hodgkin's lymphoma treatment landscape brief
- Follicular non-Hodgkin's lymphoma treatment updates RSS
Frequently asked questions about Follicular non-Hodgkin's lymphoma
What drugs treat Follicular non-Hodgkin's lymphoma?
Tracked treatments include Zevalin, Oncovin, Vincristin, Blenoxane, Cortone, Treanda, Decadron, adriacin.
What is the treatment for Follicular non-Hodgkin's lymphoma?
Standard treatment for Follicular non-Hodgkin's lymphoma includes Zevalin, Oncovin, Vincristin, Blenoxane, Cortone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Follicular non-Hodgkin's lymphoma patent cliff · Follicular non-Hodgkin's lymphoma CI report
- Treatment: Zevalin · Spectrum Pharms
- Treatment: Oncovin · University of Colorado, Denver
- Treatment: Vincristin · Arbeitsgemeinschaft medikamentoese Tumortherapie
- Treatment: Blenoxane · Bristol-Myers Squibb
- Treatment: Cortone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing